NEW YORK (TheStreet) -- RATINGS CHANGES
AOL (AOL) was downgraded at Cantor Fitzgerald to sell from buy. Twelve-month price target is $47. Analysts are downgrading AOL on the back of AOL's acquisition by Verizon (VZ) for $50 a share in an all-cash transaction.
Encana (ECA) was downgraded at RBC Capital to sector perform from outperform. Valuation call, based on a $15 price target.
Humana (HUM) was downgraded at Sterne Agee CRT to underperform. Twelve-month price target is $150. Company has potential earnings downside in the coming quarters, Sterne Agee CRT said.
Kimberly-Clark (KMB) was upgraded at Barclays to overweight from equal-weight. Twelve-month price target is $124. Organic sales growth should outperform the industry, Barclays said.
Magellan Health (MGLN) was upgraded at Jefferies to buy from hold. Twelve-month price target is $78. Since initiating two years ago, Jefferies has been patiently waiting for improved revenue visibility on MGLN's two growth initiatives and a better risk/reward profile, Jefferies said. The 14% pullback gives investors an attractive entry. Jefferies estimates Magellan Health shares are worth about $100 (60% upside) in two to three years if management executes.
Microsoft (MSFT) was upgraded at Deutsche Bank to buy from hold. Valuation call, based on a 12-month price target of $55, Deutsche Bank said.